Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors

Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors

Item
http://www.wikidata.org/entity/Q28476537
Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein-ligand interaction fingerprintSignificantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram dataInsights into an original pocket-ligand pair classification: a promising tool for ligand profile predictionMultivariate PLS Modeling of Apicomplexan FabD-Ligand Interaction Space for Mapping Target-Specific Chemical Space and Pharmacophore FingerprintsAntimicrobial peptides design by evolutionary multiobjective optimizationOn protocols and measures for the validation of supervised methods for the inference of biological networksUse of machine learning approaches for novel drug discovery.The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope.CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Modelling ligand selectivity of serine proteases using integrative proteochemometric approaches improves model performance and allows the multi-target dependent interpretation of features.Application of viromics: a new approach to the understanding of viral infections in humans.Illuminating the origins of spectral properties of green fluorescent proteins via proteochemometric and molecular modeling.Proteochemometric Modeling of the Interaction Space of Carbonic Anhydrase and its Inhibitors: An Assessment of Structure-based and Sequence-based Descriptors.Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling.Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects
P2860

Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors

Item
http://www.wikidata.org/entity/Q28476537
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteochemometric modeling of ...... verse transcriptase inhibitors
@ast
Proteochemometric modeling of ...... verse transcriptase inhibitors
@en
Proteochemometric modeling of ...... verse transcriptase inhibitors
@nl
type
label
Proteochemometric modeling of ...... verse transcriptase inhibitors
@ast
Proteochemometric modeling of ...... verse transcriptase inhibitors
@en
Proteochemometric modeling of ...... verse transcriptase inhibitors
@nl
prefLabel
Proteochemometric modeling of ...... verse transcriptase inhibitors
@ast
Proteochemometric modeling of ...... verse transcriptase inhibitors
@en
Proteochemometric modeling of ...... verse transcriptase inhibitors
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Proteochemometric modeling of ...... verse transcriptase inhibitors
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0014353
P407
P433
P478
P50
P577
P5875
P698
P932